首页> 美国卫生研究院文献>Case Reports in Nephrology >Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence
【2h】

Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence

机译:尽管有几种依赖透析的预测因素但通过糖皮质激素和血浆置换治疗抗GBM疾病的患者停止血液透析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 26-year-old man highly suspected of having antiglomerular basement membrane (GBM) disease was treated with corticosteroid pulse therapy 9 days after initial infection-like symptoms with high procalcitonin value. The patient required hemodialysis the next day of the treatment due to oliguria. In addition to corticosteroid therapy, plasmapheresis was introduced and the patient could discontinue hemodialysis 43 days after the treatment. Kidney biopsy after initiation of hemodialysis confirmed anti-GBM disease with 86.3% crescent formation. Physician should keep in mind that active anti-GBM disease shows even high procalcitonin value in the absence of infection. To pursue recovery of renal function, the challenge of the immediate and persistent treatment with high-dose corticosteroids plus plasmapheresis for highly suspected anti-GBM disease is vitally important despite the presence of reported predictors for dialysis-dependence including oliguria and requiring hemodialysis at presentation.
机译:一名高度怀疑患有抗肾小球基底膜(GBM)疾病的26岁男子在初次感染样症状(降钙素原值高)后9天接受了皮质类固醇脉冲治疗。由于尿少症,患者在治疗的第二天需要进行血液透析。除皮质类固醇激素疗法外,还引入血浆置换治疗,患者可在治疗后43天停止血液透析。血液透析开始后的肾脏活检证实抗GBM疾病,新月形成率为86.3%。医师应记住,在没有感染的情况下,活跃的抗GBM疾病甚至显示出很高的降钙素原值。为了追求肾功能的恢复,尽管存在已报道的依赖于透析的预测因素包括少尿并需要进行血液透析,但对于高度怀疑的抗GBM疾病,立即和持续用大剂量皮质类固醇联合血浆置换治疗的挑战至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号